Site içinde arama yapın

Atess Karahan bir ses eklendi Other
2026-07-14 14:44:54 -

Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Expansion Analysis and Growth Strategy Report
"According to the latest report published by Data Bridge Market Research, the Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period This Dual GIP/ GLP-1 Receptor Agonists...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!
Atess Karahan bir ses eklendi Other
2026-07-30 06:27:26 -

Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Opportunity Analysis Report
"According to the latest report published by Data Bridge Market Research, the Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period The winning Dual GIP/ GLP-1 Receptor Agonists...

0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme

Please log in to like, share and comment!
Priti Jain1999 bir ses eklendi Other
2026-10-09 05:28:45 -

GLP-1 Market: Innovation and Competitive Landscape
The GLP-1 Market is expanding as therapeutic applications move beyond diabetes into obesity and cardiovascular disease. Valued at USD 52.82 billion in 2025, the GLP-1 Market is projected to reach USD 58.48 billion in 2026 and USD 133.92 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Key players include AstraZeneca, Boehringer Ingelheim, D&D...

0 Yorumlar 0 hisse senetleri 17 Views 0 önizleme

Please log in to like, share and comment!